ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,114 | -44.6% | 483,200 | -37.3% | 0.02% | -35.3% |
| Q2 2023 | $23,691 | -49.5% | 770,700 | -40.8% | 0.03% | -45.2% |
| Q1 2023 | $46,871 | +36.5% | 1,300,900 | +49.7% | 0.06% | +31.9% |
| Q4 2022 | $34,343 | -99.5% | 869,000 | +372.5% | 0.05% | +487.5% |
| Q1 2022 | $7,165,000 | -77.5% | 183,900 | -77.0% | 0.01% | -80.0% |
| Q4 2021 | $31,844,000 | +12.4% | 799,100 | +2.0% | 0.04% | +8.1% |
| Q3 2021 | $28,319,000 | -16.6% | 783,600 | -5.4% | 0.04% | -11.9% |
| Q2 2021 | $33,964,000 | – | 828,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |